{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:42:21Z","timestamp":1790358141936,"version":"4.1.0"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/inf.0000000000000683","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T23:25:42Z","timestamp":1428708342000},"page":"635-643","source":"Crossref","is-referenced-by-count":58,"title":["European Society for Paediatric Infectious Diseases Consensus Recommendations for Rotavirus Vaccination in Europe"],"prefix":"10.1097","volume":"34","author":[{"given":"Timo","family":"Vesikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hania","family":"Szajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytautas","family":"Usonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 2","key":"R1-21-20210202","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/MPG.0b013e31816f7a10","article-title":"European Society for Paediatric Infectious DiseasesEuropean Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe.","volume":"46","author":"Vesikari","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R2-21-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00103-013-1777-3","article-title":"Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.","volume":"56","author":"Koch","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"R4-21-20210202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(14)70035-0","article-title":"Status of rotavirus vaccination in Europe: drivers and barriers.","volume":"14","author":"Parez","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R5-21-20210202","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/j.vaccine.2014.05.029","article-title":"Report of the Third European Expert Meeting on Rotavirus Vaccination: progress in rotavirus universal mass vaccination in Europe.","volume":"32","author":"Huppertz","year":"2014","journal-title":"Vaccine"},{"key":"R6-21-20210202","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1016\/j.vaccine.2011.05.017","article-title":"Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life.","volume":"29","author":"Kawamura","year":"2011","journal-title":"Vaccine"},{"key":"R7-21-20210202","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4161\/hv.24846","article-title":"Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.","volume":"9","author":"Iwata","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R8-21-20210202","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Rota-024 Study Group. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R9-21-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants.","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-21-20210202","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"R11-21-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"R14-21-20210202","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"GRADE Working Group. Grading quality of evidence and strength of recommendations.","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"R16-21-20210202","doi-asserted-by":"crossref","first-page":"e6060","DOI":"10.1371\/journal.pone.0006060","article-title":"Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis.","volume":"4","author":"Bilcke","year":"2009","journal-title":"PLoS One"},{"key":"R17-21-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children.","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"R18-21-20210202","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1542\/peds.103.1.e3","article-title":"Perinatal risk factors for infant hospitalization with viral gastroenteritis.","volume":"103","author":"Newman","year":"1999","journal-title":"Pediatrics"},{"key":"R19-21-20210202","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.inf.0000243777.01375.5b","article-title":"A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children.","volume":"25","author":"Dennehy","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R22-21-20210202","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/infdis\/164.2.277","article-title":"Protection from rotavirus reinfection: 2-year prospective study.","volume":"164","author":"Bernstein","year":"1991","journal-title":"J Infect Dis"},{"key":"R23-21-20210202","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1086\/342294","article-title":"Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, West Africa.","volume":"186","author":"Fischer","year":"2002","journal-title":"J Infect Dis"},{"key":"R24-21-20210202","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","article-title":"Rotavirus infections in infants as protection against subsequent infections.","volume":"335","author":"Velazquez","year":"1996","journal-title":"N Engl J Med"},{"key":"R25-21-20210202","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(84)92323-7","article-title":"Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.","volume":"1","author":"Vesikari","year":"1984","journal-title":"Lancet"},{"key":"R27-21-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0264-410X(97)00210-7","article-title":"Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.","volume":"16","author":"Bernstein","year":"1998","journal-title":"Vaccine"},{"key":"R28-21-20210202","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.vaccine.2004.01.044","article-title":"Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants.","volume":"22","author":"Vesikari","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"R30-21-20210202","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/infdis\/174.Supplement_1.S73","article-title":"The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.","volume":"174","author":"Clark","year":"1996","journal-title":"J Infect Dis"},{"key":"R31-21-20210202","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.vaccine.2006.03.025","article-title":"Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.","volume":"24","author":"Vesikari","year":"2006","journal-title":"Vaccine"},{"key":"R33-21-20210202","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.inf.0000141722.10130.50","article-title":"Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.","volume":"23","author":"Vesikari","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R34-21-20210202","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R35-21-20210202","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/431511","article-title":"Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.","volume":"192","author":"Phua","year":"2005","journal-title":"J Infect Dis"},{"key":"R36-21-20210202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.inf.0000178294.13954.a1","article-title":"Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants.","volume":"24","author":"Salinas","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R37-21-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"R38-21-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"R39-21-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Pentavalent Rotavirus Vaccine Dose Confirmation Efficacy Study Group. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"key":"R40-21-20210202","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","article-title":"RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.","volume":"28","author":"Vesikari","year":"2010","journal-title":"Vaccine"},{"key":"R41-21-20210202","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00431-010-1242-3","article-title":"Efficacy of the pentavalent rotavirus vaccine, RotaTeq, in Finnish infants up to 3 years of age: the Finnish extension study.","volume":"169","author":"Vesikari","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R42-21-20210202","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1016\/j.vaccine.2011.04.098","article-title":"Impact of rotavirus vaccination on laboratory confirmed cases in Belgium.","volume":"29","author":"Hanquet","year":"2011","journal-title":"Vaccine"},{"key":"R43-21-20210202","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/INF.0b013e318214b811","article-title":"Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium.","volume":"30","author":"Raes","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R44-21-20210202","doi-asserted-by":"crossref","first-page":"e4752","DOI":"10.1136\/bmj.e4752","article-title":"RotaBel Study Group. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.","volume":"345","author":"Braeckman","year":"2012","journal-title":"BMJ"},{"key":"R45-21-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/INF.0b013e3181c18434","article-title":"Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children.","volume":"29","author":"Paulke-Korinek","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R46-21-20210202","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2011.01.104","article-title":"Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.","volume":"29","author":"Paulke-Korinek","year":"2011","journal-title":"Vaccine"},{"key":"R47-21-20210202","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.vaccine.2012.10.068","article-title":"First year experience of rotavirus immunisation programme in Finland.","volume":"31","author":"Leino","year":"2012","journal-title":"Vaccine"},{"key":"R48-21-20210202","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00431-013-1945-3","article-title":"Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.","volume":"172","author":"Hemming","year":"2013","journal-title":"Eur J Pediatr"},{"key":"R49-21-20210202","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/INF.0000000000000086","article-title":"Impact and effectiveness of RotaTeq vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.","volume":"32","author":"Vesikari","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R52-21-20210202","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4161\/hv.21593","article-title":"Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.","volume":"8","author":"Dudareva-Vizule","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R53-21-20210202","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/INF.0b013e3182720b71","article-title":"Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.","volume":"32","author":"Adlhoch","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R54-21-20210202","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/INF.0b013e318214b811","article-title":"Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium.","volume":"30","author":"Raes","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R56-21-20210202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.coviro.2012.05.002","article-title":"Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.","volume":"2","author":"Lopman","year":"2012","journal-title":"Curr Opin Virol"},{"key":"R58-21-20210202","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2010-1393","article-title":"Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction.","volume":"127","author":"Yen","year":"2011","journal-title":"Pediatrics"},{"key":"R59-21-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","article-title":"Effect of rotavirus vaccination on death from childhood diarrhea in Mexico.","volume":"362","author":"Richardson","year":"2010","journal-title":"N Engl J Med"},{"key":"R60-21-20210202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/cit671","article-title":"Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children.","volume":"58","author":"Payne","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R61-21-20210202","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/0883073807307083","article-title":"Rotavirus-induced seizures in childhood.","volume":"22","author":"DiFazio","year":"2007","journal-title":"J Child Neurol"},{"key":"R62-21-20210202","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1371\/journal.pmed.0040121","article-title":"Rotavirus antigenemia in children is associated with viremia.","volume":"4","author":"Blutt","year":"2007","journal-title":"PLoS Med"},{"key":"R63-21-20210202","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/INF.0000000000000118","article-title":"Rotavirus antigenemia in children is associated with more severe clinical manifestations of acute gastroenteritis.","volume":"33","author":"Hemming","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R64-21-20210202","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00705-007-0028-z","article-title":"Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.","volume":"153","author":"Nakagomi","year":"2008","journal-title":"Arch Virol"},{"key":"R65-21-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/INF.0b013e3181e7886a","article-title":"Hospital-based surveillance to evaluate the impact of rotavirus vaccination in Sao Paulo, Brazil.","volume":"29","author":"Safadi","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R66-21-20210202","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1016\/j.vaccine.2010.09.004","article-title":"Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium.","volume":"28","author":"Zeller","year":"2010","journal-title":"Vaccine"},{"key":"R69-21-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.inf.0000164763.55558.71","article-title":"North American Human Rotavirus Vaccine Study Group. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.","volume":"24","author":"Dennehy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R70-21-20210202","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1016\/j.vaccine.2011.03.074","article-title":"Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.","volume":"29","author":"Yen","year":"2011","journal-title":"Vaccine"},{"key":"R71-21-20210202","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.vaccine.2013.08.041","article-title":"Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.","volume":"32","author":"Hsieh","year":"2014","journal-title":"Vaccine"},{"key":"R72-21-20210202","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1016\/j.vaccine.2011.10.015","article-title":"Horizontal transmission of a human rotavirus vaccine strain-a randomized, placebo-controlled study in twins.","volume":"29","author":"Rivera","year":"2011","journal-title":"Vaccine"},{"key":"R73-21-20210202","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1542\/peds.2009-1901","article-title":"Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis.","volume":"125","author":"Payne","year":"2010","journal-title":"Pediatrics"},{"key":"R75-21-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jis361","article-title":"Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.","volume":"206","author":"Donato","year":"2012","journal-title":"J Infect Dis"},{"key":"R78-21-20210202","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine.","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"R80-21-20210202","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/367895","article-title":"Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions.","volume":"187","author":"Murphy","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"R82-21-20210202","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: the role of age at the time of vaccination.","volume":"192","author":"Simonsen","year":"2005","journal-title":"J Infect Dis"},{"key":"R83-21-20210202","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R84-21-20210202","first-page":"734","article-title":"Postmarketing surveillance of intussusception following mass introduction of the live attenuated human rotavirus vaccine in Mexico.","volume":"31","author":"Velasquez","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R85-21-20210202","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"PAEDSAPSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the national immunization program in Australia.","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"R86-21-20210202","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1542\/peds.2007-3793","article-title":"Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.","volume":"121","author":"Haber","year":"2008","journal-title":"Pediatrics"},{"key":"R87-21-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/infdis\/jis314","article-title":"Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.","volume":"206","author":"Yen","year":"2012","journal-title":"J Infect Dis"},{"key":"R88-21-20210202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination.","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"key":"R91-21-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000254391.71103.e8","article-title":"Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States.","volume":"26","author":"Rodriguez","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R93-21-20210202","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1086\/653550","article-title":"Concomitant administration of a live-attenuated oral rotavirus vaccine (RIX4414) with poliovirus vaccines in African infants.","volume":"202","author":"Steele","year":"2010","journal-title":"J Infect Dis"},{"key":"R94-21-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R95-21-20210202","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/INF.0b013e3182720b71","article-title":"Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.","volume":"32","author":"Adlhoch","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R96-21-20210202","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/INF.0b013e3182489cac","article-title":"Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.","volume":"31","author":"Vesikari","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R97-21-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2471\/BLT.13.128066","article-title":"Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.","volume":"92","author":"Groome","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"R98-21-20210202","doi-asserted-by":"crossref","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","article-title":"Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.","volume":"32","author":"Rongsen-Chandola","year":"2014","journal-title":"Vaccine"},{"key":"R99-21-20210202","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00005176-199611000-00026","article-title":"Rotavirus infection and diarrhea in healthy and HIV-infected children: a cohort study.","volume":"23","author":"Fontana","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R100-21-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(02)07287-2","article-title":"HIV, fatal rotavirus infection, and treatment options.","volume":"359","author":"Guarino","year":"2002","journal-title":"Lancet"},{"key":"R102-21-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/INF.0b013e3181f42db9","article-title":"Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa.","volume":"30","author":"Steele","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"R103-21-20210202","doi-asserted-by":"crossref","first-page":"A61","DOI":"10.1016\/j.vaccine.2011.09.026","article-title":"Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(), in Kenya, including among HIV-infected and HIV-exposed infants.","volume":"30","author":"Laserson","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"R104-21-20210202","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/j.vaccine.2011.08.043","article-title":"Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.","volume":"30","author":"Feikin","year":"2012","journal-title":"Vaccine"},{"key":"R105-21-20210202","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1016\/j.vaccine.2012.06.079","article-title":"Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIV.","volume":"30","author":"Banda","year":"2012","journal-title":"Vaccine"},{"key":"R106-21-20210202","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1473-3099(14)70940-5","article-title":"Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhea in South African children: a case control study.","volume":"14","author":"Groome","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R107-21-20210202","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/00365540802415509","article-title":"Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance.","volume":"40","author":"Johansen","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"R108-21-20210202","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaci.2009.07.005","article-title":"Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency.","volume":"124","author":"Werther","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R109-21-20210202","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2010.07.039","article-title":"Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the vaccine adverse events reporting system (VAERS).","volume":"28","author":"Bakare","year":"2010","journal-title":"Vaccine"},{"key":"R110-21-20210202","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/mi.2012.51","article-title":"IgA is important for clearance and critical for protection from rotavirus infection.","volume":"5","author":"Blutt","year":"2012","journal-title":"Mucosal Immunol"},{"key":"R111-21-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pedneo.2011.11.005","article-title":"Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit.","volume":"53","author":"Shim","year":"2012","journal-title":"Pediatr Neonatol"},{"key":"R114-21-20210202","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/INF.0b013e3182490a2c","article-title":"ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.","volume":"31","author":"Omenaca","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:06:46Z","timestamp":1620954406000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201506000-00021"}},"subtitle":["Update 2014"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000683","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}